Product Categories
| Country: | China |
|---|---|
| Tel: | 021-59167510 |
| Mobile: | 18117107507 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Erastin2 | C36H35ClN4O4 | 1695533-44-8 | Details |
| Ozagrel | C13H12N2O2 | 82571-53-7 | Details |
| Betrixaban | C23H22ClN5O3 | 330942-05-7 | Details |
| GSK2256098 | C20H23ClN6O2 | 1224887-10-8 | Details |
| Conteltinib | C32H45N9O3S | 1384860-29-0 | Details |
| BI-3663 | C44H42F3N7O12 | 2341740-84-7 | Details |
| PROTAC FAK degrader 1 | C47H56F3N9O8S2 | 2301916-69-6 | Details |
| Ifebemtinib | C28H28F4N6O4 | 1227948-82-4 | Details |
| Defactinib | C20H21F3N8O3S | 1073154-85-4 | Details |
| BI-4464 | C28H28F3N5O4 | 1227948-02-8 | Details |
| GSK215 | C50H59F3N10O6S | 2743427-26-9 | Details |
| PND-1186 | C25H26F3N5O3 | 1061353-68-1 | Details |
| FAPI-46 | C41H57F2N11O9 | 2374782-04-2 | Details |
| FAPI-34 | C50H57F2N13O18 | 2374782-07-5 | Details |
| OncoFAP | C21H19F2N5O5 | 2639365-69-6 | Details |
| FAP-2286 | C67H99N13O18S3 | 2581741-18-4 | Details |
| MB05032 | C11H15N2O4PS | 261365-11-1 | Details |
| ML-210 | C22H20Cl2N4O4 | 1360705-96-9 | Details |
| Linagliptin | C25H28N8O2 | 668270-12-0 | Details |
| Linagliptin-d4 | C25H28N8O2 | 2140263-92-7 | Details |
| FIN56 | C25H31N3O5S2 | 1083162-61-1 | Details |
| UAMC-3203 hydrochloride | C25H38ClN5O2S | 2271358-65-5 | Details |
| iFSP1 | C20H13N5 | 150651-39-1 | Details |
| Pioglitazone | C19H20N2O3S | 111025-46-8 | Details |
| Pioglitazone-d4 | C19H16D4N2O3S | 1134163-29-3 | Details |
| GPX4-IN-3 | C29H24ClN3O3S | 2761004-85-5 | Details |
| MMRi62 | C21H15Cl2N3O | 352693-80-2 | Details |
| Erastin | C30H31ClN4O4 | 571203-78-6 | Details |
| Pifithrin-β hydrobromide | C16H16N2S.HBr | 511296-88-1 | Details |
| Deferasirox | C21H15N3O4 | 201530-41-8 | Details |
| Dopamine-d5 (hydrochloride) | C8H12ClNO2 | 2193106-55-5 | Details |
| NADPH tetrasodium salt | C21H31N7NaO17P3 | 2646-71-1 | Details |
| Eugenol-d3 | C10H12O2 | 1335401-17-6 | Details |
| Alogliptin-d3 | C18H21N5O2 | 1133421-35-8 | Details |
| Setanaxib | C21H19ClN4O2 | 1218942-37-0 | Details |
| Alogliptin Benzoate | C25H27N5O4 | 850649-62-6 | Details |
| Liproxstatin-1 HCl(free base) | C19H21ClN4 | 950455-15-9 | Details |
| Rogaratinib | C23H26N6O3S | 1443530-05-9 | Details |
| JWG-071 | C34H44N8O3 | 2250323-50-1 | Details |
| Tizaterkib | C24H24F2N8O2 | 2097416-76-5 | Details |
| BAY885 | C25H28F3N7O2 | 2307249-33-6 | Details |
| KO-947 | C21H17N5O | 1695533-89-1 | Details |
| ERK1/2 inhibitor 1 | C29H32ClN5O4 | 2095719-90-5 | Details |
| CC-90003 | C22H21F3N6O2 | 1621999-82-3 | Details |
| Rineterkib | C26H27BrF3N5O2 | 1715025-32-3 | Details |
| URB597 | C20H22N2O3 | 546141-08-6 | Details |
| BMS-309403 sodium | C31H27N2NaO3 | 2802523-05-1 | Details |
| BMS-962212 | C32H28ClFN8O5 | 1430114-34-3 | Details |
| Asundexian | C26H21ClF4N6O4 | 2064121-65-7 | Details |
| Darexaban | C27H30N4O4 | 365462-23-3 | Details |
| Apixaban-13C,d3 | C2413CH22D3N5O4 | 1261393-15-0 | Details |
| Edoxaban tosylate | C24H30ClN7O4S.C7H8O3S | 480449-71-6 | Details |
| DY131 | C18H21N3O2 | 95167-41-2 | Details |
| Rineterkib hydrochloride | C26H28BrClF3N5O2 | 1715025-34-5 | Details |
| BIX02188 | C25H24N4O2 | 334949-59-6 | Details |
| FR 180204 | C18H13N7 | 865362-74-9 | Details |
| ASTX029 | C29H31ClFN5O5 | 2095719-92-7 | Details |
| ERK-IN-3 | C22H25ClFN7O2 | 2055597-12-9 | Details |
| DMU-212 | C18H20O4 | 134029-62-2 | Details |
| MAP855 | C28H23ClF2N6O3 | 1660107-77-6 | Details |
| Anti-inflammatory agent 35 | C27H29NO8 | 2293951-00-3 | Details |
| RLX-33 | C24H19ClN4O4 | 2784577-71-3 | Details |
| XMD17-109 | C36H46N8O3 | 1435488-37-1 | Details |
| Ulixertinib | C21H22Cl2N4O2 | 869886-67-9 | Details |
| Ravoxertinib | C21H18ClFN6O2 | 1453848-26-4 | Details |
| LM22B-10 | C27H33ClN2O4 | 342777-54-2 | Details |
| Lidocaine hydrochloride | C14H23ClN2O | 73-78-9 | Details |
| EF24 | C19H15F2NO | 342808-40-6 | Details |
| CK2/ERK8-IN-1 | C11H9Br4N3O2 | 1085822-09-8 | Details |
| (rel)-AR234960 | C27H30FN5O5S | 1408311-94-3 | Details |
| Lidocaine | C14H22N2O | 137-58-6 | Details |
| VX-11e | C24H20Cl2FN5O2 | 896720-20-0 | Details |
| Ulixertinib (hydrochloride) | C21H23Cl3N4O2 | 1956366-10-1 | Details |
| ODM-203 | C26H21F2N5O2S | 1430723-35-5 | Details |
| BLU9931 | C26H22Cl2N4O3 | 1538604-68-0 | Details |
| CPL304110 | C25H30N6O2 | 1627826-19-0 | Details |
| Gunagratinib | C22H25N5O4 | 2211082-53-8 | Details |
| CP-547632 | C20H24BrF2N5O3S | 252003-65-9 | Details |
| CP-547632 hydrochloride | C20H25BrClF2N5O3S | 252003-71-7 | Details |
| R1530 | C18H14ClFN4O | 882531-87-5 | Details |
| FGFR-IN-1 | C26H24F2N4O6S | 1513860-41-7 | Details |
| SSR128129E | C18H15N2NaO4 | 848318-25-2 | Details |
| FIIN-2 | C35H38N8O4 | 1633044-56-0 | Details |
| JK-P3 | C18H17N3O3 | 942655-44-9 | Details |
| Pemigatinib | C24H27F2N5O4 | 1513857-77-6 | Details |
| KHS101 hydrochloride | C18H22ClN5S | 1784282-12-7 | Details |
| Nintedanib esylate | C33H39N5O7S | 656247-18-6 | Details |
| Tyrosine kinase-IN-1 | C26H28FN5O | 705946-27-6 | Details |
| Fisogatinib | C24H24Cl2N4O4 | 1707289-21-1 | Details |
| FGFR4-IN-1 | C24H27N7O5 | 1708971-72-5 | Details |
| PD-166866 | C20H24N6O3 | 192705-79-6 | Details |
| E7090 | C32H37N5O6 | 1622204-21-0 | Details |
| E7090 succinate | C36H43N5O10 | 1879965-80-6 | Details |
| (Z)-Orantinib | C18H18N2O3 | 210644-62-5 | Details |
| NSC12 | C24H34F6O3 | 102586-30-1 | Details |
| AR-9281 | C18H29N3O2 | 913548-29-5 | Details |
| SWE101 | C19H15Cl2NO3 | 2376322-12-0 | Details |
| sEH inhibitor-7 | C15H21NO2 | 340221-20-7 | Details |
| GSK2256294A | C21H24F3N7O | 1142090-23-0 | Details |
| AX-15836 | C32H40N8O5S | 2035509-96-5 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 | ||||